Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Laura Cortesi

Showing results (101-110 of 181) with videos related to

Pageof 19
Sort By:
Genes|January 26, 2021
Characterization of New <i>ATM</i> Deletion Associated with Hereditary Breast CancerSandra Parenti, Claudio Rabacchi, Marco Marino, et al.
Human Mutation|January 5, 2026
Characterization of Copy Number Variants in Hereditary Cancer Patients Through NGS Shows a Distinctive PALB2 Contribution to the Diagnostic YieldLia Bonamici, Lucia Artuso, Marco Marino, et al.
International Journal of Molecular Sciences|June 2, 2021
Detecting Variants in the NBN Gene While Testing for Hereditary Breast Cancer: What to Do Next?Roberta Zuntini, Elena Bonora, Laura Maria Pradella, et al.
Cancers|February 10, 2019
Hereditary Pancreatic Cancer: A Retrospective Single-Center Study of 5143 Italian Families with History of BRCA-Related MalignanciesAngela Toss, Marta Venturelli, Eleonora Molinaro, et al.
Diagnosis (Berlin, Germany)|June 18, 2021
Automated capture-based NGS workflow: one thousand patients experience in a clinical routine frameworkElena Tenedini, Fabio Celestini, Pierluigi Iapicca, et al.
Genes|April 30, 2021
Clinicopathologic Profile of Breast Cancer in Germline ATM and CHEK2 Mutation CarriersAngela Toss, Elena Tenedini, Claudia Piombino, et al.
Current Oncology (Toronto, Ont.)|February 26, 2026
Patient Journey for Triple-Negative Breast Cancer: Optimal Care Pathways vs. Reality of Care in Italian Breast UnitsNicla La Verde, Luisa Brogonzoli, Maria Silvia Cona, et al.
Molecular Cancer|August 4, 2009
Elongation Factor 1 alpha interacts with phospho-Akt in breast cancer cells and regulates their proliferation, survival and motilityLuisa Pecorari, Oriano Marin, Chiara Silvestri, et al.
Oncotarget|February 11, 2017
BRCA1 p.His1673del is a pathogenic mutation associated with a predominant ovarian cancer phenotypeRoberta Zuntini, Laura Cortesi, Daniele Calistri, et al.
The Lancet. Oncology|April 30, 2026
CDK4/6 inhibitors plus endocrine therapy versus endocrine monotherapy in hormone receptor-positive, HER2-negative advanced breast cancer: a reconstructed individual patient data meta-analysis of phase 3 randomised controlled trialsMohammed S Beshr, Ammar Fahaid, Rana H Shembesh, et al.
Pageof 19

Showing results (101-110 of 181) with videos related to

Sort By:
Pageof 19
Genes|January 26, 2021
Characterization of New <i>ATM</i> Deletion Associated with Hereditary Breast CancerSandra Parenti, Claudio Rabacchi, Marco Marino, et al.
Human Mutation|January 5, 2026
Characterization of Copy Number Variants in Hereditary Cancer Patients Through NGS Shows a Distinctive PALB2 Contribution to the Diagnostic YieldLia Bonamici, Lucia Artuso, Marco Marino, et al.
International Journal of Molecular Sciences|June 2, 2021
Detecting Variants in the NBN Gene While Testing for Hereditary Breast Cancer: What to Do Next?Roberta Zuntini, Elena Bonora, Laura Maria Pradella, et al.
Cancers|February 10, 2019
Hereditary Pancreatic Cancer: A Retrospective Single-Center Study of 5143 Italian Families with History of BRCA-Related MalignanciesAngela Toss, Marta Venturelli, Eleonora Molinaro, et al.
Diagnosis (Berlin, Germany)|June 18, 2021
Automated capture-based NGS workflow: one thousand patients experience in a clinical routine frameworkElena Tenedini, Fabio Celestini, Pierluigi Iapicca, et al.
Genes|April 30, 2021
Clinicopathologic Profile of Breast Cancer in Germline ATM and CHEK2 Mutation CarriersAngela Toss, Elena Tenedini, Claudia Piombino, et al.
Current Oncology (Toronto, Ont.)|February 26, 2026
Patient Journey for Triple-Negative Breast Cancer: Optimal Care Pathways vs. Reality of Care in Italian Breast UnitsNicla La Verde, Luisa Brogonzoli, Maria Silvia Cona, et al.
Molecular Cancer|August 4, 2009
Elongation Factor 1 alpha interacts with phospho-Akt in breast cancer cells and regulates their proliferation, survival and motilityLuisa Pecorari, Oriano Marin, Chiara Silvestri, et al.
Oncotarget|February 11, 2017
BRCA1 p.His1673del is a pathogenic mutation associated with a predominant ovarian cancer phenotypeRoberta Zuntini, Laura Cortesi, Daniele Calistri, et al.
The Lancet. Oncology|April 30, 2026
CDK4/6 inhibitors plus endocrine therapy versus endocrine monotherapy in hormone receptor-positive, HER2-negative advanced breast cancer: a reconstructed individual patient data meta-analysis of phase 3 randomised controlled trialsMohammed S Beshr, Ammar Fahaid, Rana H Shembesh, et al.
Pageof 19